Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Post by longondmxon Jan 15, 2014 1:48pm

294 Views

Post# 22094812

hit a 52-week high today

That should put the stock on the radar of some more people. Can't see this letting up given that the Jan 23 date to hear the patent challenge by Novartis is coming up.

The European Patent Office has set a date of January 23, 2014 to hear the VIRUSMAX® patent challenge by Novartis.

Wonder how long the hearing will be? And when we could expect a decision? Anyone have any ideas?

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario